Peg-interferon Plus Ribavirin Combination Therapy in HCV Mono-infected and HCV/HIV Co-infected Patients in Iran

Background: Hepatitis C virus (HCV) infection is a cause of major liver complications, particularly in patients infected with human immunodeficiency virus (HIV). This study aimed to evaluate the efficacy of pegylated interferon (Peg-IFN) and a fixed dose of ribavirin treatment among Iranian HCV mono...

Descripción completa

Detalles Bibliográficos
Autores principales: Hesamizadeh, Khashayar, Tavakoli, Ahmad, Nikbin, Mehri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708113/
https://www.ncbi.nlm.nih.gov/pubmed/31456987
http://dx.doi.org/10.34171/mjiri.33.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708113/
https://www.ncbi.nlm.nih.gov/pubmed/31456987
http://dx.doi.org/10.34171/mjiri.33.63

Ejemplares similares